| Rebecca Penaranda, AUD | |
|
1245 Highland Ave Ste 502, Abington, PA 19001-3726 | |
| (215) 886-1482 | |
| Not Available |
| Full Name | Rebecca Penaranda |
|---|---|
| Gender | Female |
| Speciality | Qualified Audiologist |
| Experience | 4 Years |
| Location | 1245 Highland Ave Ste 502, Abington, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164045001 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | (* (Not Available)) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Jefferson University Physicians | 7911819180 | 1269 |
News Archive
ZOLL Medical Corporation announced today that it will participate in a conference call hosted by SunTrust Robinson Humphrey on Thursday, December 10, 2009 at 10:30am EST to discuss the LifeVest® wearable defibrillator business.
The first advance in pancreatic cancer treatment in a decade has been achieved by researchers in a Canadian-led study, and at last gives some encouragement to scientists and invigorates a field that has experienced more than its share of disheartening failures.
Sun Pharmaceutical Industries Ltd. announced that USFDA has granted its subsidiary a tentative approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Forest Laboratories, Inc.'s Namenda 5 mg and 10 mg tablets.
Kessler Foundation researchers published a subanalysis of their MEMREHAB trial, which shows that treatment with the modified Story Memory Technique (mSMT) may be affected by cognitive dysfunction. Investigators looked at the influence of processing speed on benefits of the mSMT, a 10-session cognitive intervention protocol shown to improve new learning and memory in individuals with MS.
› Verified 7 days ago
| Provider Name | Jefferson University Physicians |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1326093675 PECOS PAC ID: 7911819180 Enrollment ID: O20040225000232 |
News Archive
ZOLL Medical Corporation announced today that it will participate in a conference call hosted by SunTrust Robinson Humphrey on Thursday, December 10, 2009 at 10:30am EST to discuss the LifeVest® wearable defibrillator business.
The first advance in pancreatic cancer treatment in a decade has been achieved by researchers in a Canadian-led study, and at last gives some encouragement to scientists and invigorates a field that has experienced more than its share of disheartening failures.
Sun Pharmaceutical Industries Ltd. announced that USFDA has granted its subsidiary a tentative approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Forest Laboratories, Inc.'s Namenda 5 mg and 10 mg tablets.
Kessler Foundation researchers published a subanalysis of their MEMREHAB trial, which shows that treatment with the modified Story Memory Technique (mSMT) may be affected by cognitive dysfunction. Investigators looked at the influence of processing speed on benefits of the mSMT, a 10-session cognitive intervention protocol shown to improve new learning and memory in individuals with MS.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rebecca Penaranda, AUD 418 S Queen Anne Dr, Fairless Hills, PA 19030-3023 Ph: (267) 709-8527 | Rebecca Penaranda, AUD 1245 Highland Ave Ste 502, Abington, PA 19001-3726 Ph: (215) 886-1482 |
News Archive
ZOLL Medical Corporation announced today that it will participate in a conference call hosted by SunTrust Robinson Humphrey on Thursday, December 10, 2009 at 10:30am EST to discuss the LifeVest® wearable defibrillator business.
The first advance in pancreatic cancer treatment in a decade has been achieved by researchers in a Canadian-led study, and at last gives some encouragement to scientists and invigorates a field that has experienced more than its share of disheartening failures.
Sun Pharmaceutical Industries Ltd. announced that USFDA has granted its subsidiary a tentative approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Forest Laboratories, Inc.'s Namenda 5 mg and 10 mg tablets.
Kessler Foundation researchers published a subanalysis of their MEMREHAB trial, which shows that treatment with the modified Story Memory Technique (mSMT) may be affected by cognitive dysfunction. Investigators looked at the influence of processing speed on benefits of the mSMT, a 10-session cognitive intervention protocol shown to improve new learning and memory in individuals with MS.
› Verified 7 days ago
Julia Rainsford, AU.D Audiologist Medicare: Medicare Enrolled Practice Location: 1245 Highland Ave, Suite 502, Abington, PA 19001 Phone: 215-886-1482 Fax: 215-886-1491 | |
Mrs. Robin Dubowe Einhorn, Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1245 Highland Ave, Suite 502, Abington, PA 19001 Phone: 215-886-1482 Fax: 215-886-1491 |